DFTX vs TRLV: stock comparison and AI forecast
Definium Therapeutics, Inc. (DFTX) and Trulieve Cannabis Corp. (TRLV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DFTX Definium Therapeutics, Inc.
- Market Cap
- $4.08B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
TRLV Trulieve Cannabis Corp.
- Market Cap
- $1.86B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DFTX is 2.2 times larger than TRLV by market capitalization ($4.08B against $1.86B).
- TRLV carries 1.74 times debt per unit of equity, against 0.21 times for DFTX.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DFTX | TRLV |
|---|---|---|
| Market Cap | $4.08B | $1.86B |
| P/B Ratio | 4.44x | 2.41x |
| EPS | $-3.00 | $-2.53 |
| Book Value/Share | $6.84 | $4.53 |
| Revenue/Share | – | $6.34 |
| FCF/Share | – | $1.03 |
Profitability & Margins
| Metric | DFTX | TRLV |
|---|---|---|
| ROE | -38.5% | -57.6% |
| ROA | -31.8% | -21.0% |
| ROIC | -23.8% | -13.7% |
| Gross Margin | – | 60.6% |
| Operating Margin | – | -25.6% |
| Net Margin | – | -41.2% |
| EBT Margin | – | -30.4% |
| Tax Rate | – | -35.9% |
Financial Health
| Metric | DFTX | TRLV |
|---|---|---|
| Current Ratio | 6.95x | 5.52x |
| Quick Ratio | – | 3.65x |
| D/E Ratio | 0.21x | 1.74x |
| Financial Leverage | 1.21x | 2.74x |
| Interest Coverage | -60.9x | 5.8x |
| Working Capital | $935M | $461M |
Cash Flow
| Metric | DFTX | TRLV |
|---|---|---|
| Operating Cash Flow | -$168M | $242M |
| Free Cash Flow | – | $176M |
| Capital Spending | – | -$67M |
| OCF Growth YoY | – | -0.7% |
| FCF Growth YoY | – | 9.0% |
| FCF/Sales | – | 16.2% |
| CapEx/Sales | – | 6.2% |
Operational Efficiency
| Metric | DFTX | TRLV |
|---|---|---|
| Asset Turnover | – | 0.51x |
| Receivables Turnover | – | 288.3x |
| Inventory Turnover | – | 2.2x |
| Fixed Assets Turnover | – | 1.8x |
| Days Sales Outstanding | – | 1 days |
| Days Inventory | – | 164 days |
| Payables Period | – | 58 days |
| Cash Conversion Cycle | – | 106 days |
Income Statement
| Metric | DFTX | TRLV |
|---|---|---|
| Total Revenue | – | $1.08B |
| Operating Income | -$228M | -$277M |
| Net Income | -$354M | -$446M |
| R&D Expense | $155M | – |
| SG&A Expense | – | $421M |
| Cost of Goods Sold | – | $426M |
Dividend & Shareholder Information
| Metric | DFTX | TRLV |
|---|---|---|
| Shares Outstanding | 134M | 171M |
DFTX vs TRLV: stock comparison and AI forecast
Which is bigger, DFTX or TRLV?
DFTX is 2.2 times larger than TRLV by market capitalization ($4.08B against $1.86B).
Which one does Intratio's AI model rank higher, DFTX or TRLV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.